Drugs Made In Stock Alpha and Beta Analysis

DMAA Stock   10.40  0.02  0.19%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Drugs Made In. It also helps investors analyze the systematic and unsystematic risks associated with investing in Drugs Made over a specified time horizon. Remember, high Drugs Made's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Drugs Made's market risk premium analysis include:
Beta
0.0081
Alpha
0.006732
Risk
0.0887
Sharpe Ratio
0.18
Expected Return
0.0159
Please note that although Drugs Made alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Drugs Made did 0.01  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Drugs Made In stock's relative risk over its benchmark. Drugs Made In has a beta of 0.01  . As returns on the market increase, Drugs Made's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drugs Made is expected to be smaller as well. As of January 15, 2026, Book Value Per Share is expected to decline to -0. In addition to that, Net Current Asset Value is expected to decline to 3,356.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Drugs Made Backtesting, Drugs Made Valuation, Drugs Made Correlation, Drugs Made Hype Analysis, Drugs Made Volatility, Drugs Made History and analyze Drugs Made Performance.

Drugs Made Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Drugs Made market risk premium is the additional return an investor will receive from holding Drugs Made long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Drugs Made. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Drugs Made's performance over market.
α0.01   β0.01

Drugs Made expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Drugs Made's Buy-and-hold return. Our buy-and-hold chart shows how Drugs Made performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Drugs Made Market Price Analysis

Market price analysis indicators help investors to evaluate how Drugs Made stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Drugs Made shares will generate the highest return on investment. By understating and applying Drugs Made stock market price indicators, traders can identify Drugs Made position entry and exit signals to maximize returns.

Drugs Made Return and Market Media

The median price of Drugs Made for the period between Fri, Oct 17, 2025 and Thu, Jan 15, 2026 is 10.33 with a coefficient of variation of 0.27. The daily time series for the period is distributed with a sample standard deviation of 0.03, arithmetic mean of 10.34, and mean deviation of 0.02. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Pharma Titan Slides As Generics Slam Its Biggest Moneymaker - Investors Business Daily
10/28/2025
2
REGN, GMAB, ARWR Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov - TipRanks
11/13/2025
3
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead - AOL.com
11/17/2025
4
Cathie Wood pivots to AI drug discovery, gene editing stocks, reduces diagnostics and software exposure - Seeking Alpha
11/24/2025
5
Pfizers Cancer Drugs Deliver Growth Amid Competitive Pressure - Zacks Investment Research
12/02/2025
6
JNJ vs. PFE Which Blue-Chip Drug Stock is the Better Investment Now - Nasdaq
12/10/2025
7
Trumps Giving Cannabis Stocks a Liftand the Optimism May Be Justified - Barrons
12/16/2025
8
RPTX Stock Soars Pre-Market After Gilead Agrees To Acquire Investigational Cancer Drug - Stocktwits
12/24/2025
9
Is It Time to Dump Your Shares of Eli Lilly - The Globe and Mail
01/05/2026
10
Dietary supplement recalled over risk of life-threatening events
01/13/2026

About Drugs Made Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Drugs or other stocks. Alpha measures the amount that position in Drugs Made In has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2025 2026 (projected)
Income Quality0.620.550.5
Net Current Asset Value4.2K3.8K3.4K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Drugs Made in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Drugs Made's short interest history, or implied volatility extrapolated from Drugs Made options trading.

Build Portfolio with Drugs Made

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Drugs Made In is a strong investment it is important to analyze Drugs Made's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Drugs Made's future performance. For an informed investment choice regarding Drugs Stock, refer to the following important reports:
Check out Drugs Made Backtesting, Drugs Made Valuation, Drugs Made Correlation, Drugs Made Hype Analysis, Drugs Made Volatility, Drugs Made History and analyze Drugs Made Performance.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Drugs Made technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Drugs Made trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...